Eikon Therapeutics Inc. – Filings and Transcripts

NASDAQ: EIKN
Share price (10/1/26): $7.41
Market cap (10/1/26): $401 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/26 Q2

ended 03/31/26 Q1

ended 12/31/25 FY 2025

Prospectuses and Registrations Filter

Registration of securities for employees

Prospectus supplement with pricing info

Addition of securities to prior initial registration

Registration of securities on exchange

Initial registration of new securities – amended

Ownership Filter

Svennilson Peter, Kutzkey Tim, Column Group IV-A, LP, Column Group IV, LP, Column Group IV GP, LP, Column Group Opportunity III, LP, TCG Opportunity III GP, LLC, Column Group Opportunity III GP, LP

Francisco Ma. Fatima

Innovation Endeavors III LP

Perlmutter Roger M

News Filter

Investor Presentation

Reports Second Quarter 2026 Financial Results and Provides Clinical Updates

Change in Directors, Officers or Compensation

Change in Directors, Officers or Compensation

Presents Data on Clinical-Stage Programs at the 2026 Annual Meeting of the American Society of Clinical Oncology

Proxies

No filings in this category.

Other Filter

Notice of effectiveness